Ahmedabad, India 05th June : Torrent Pharmaceuticals Limited (Torrent) today announced  that it has entered into a non-exclusive patent licensing agreement with Takeda to commercialize  Vonoprazan in India. Vonoprozan is a novel potassium-competitive acid blocker (P-CAB), used for  the treatment of acid related disorders – Gastroesophageal Reflux Disease (GERD). Torrent will  market Vonoprazan under its […]